VMP 35025711000001101

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Testosterone 16.2mg/g transdermal gel (20.25mg per actuation)
BNF code 0604020K0AABQBQ
Virtual Therapeutic Moiety Testosterone
Abbreviated name Testosterone 16.2mg/g gel (20.25mg per actuation)
Basis of preferred name rINN - Recommended International Non-proprietary
Date of name applicability 1 Nov 2023
Previous name Testosterone 16.2mg/g gel (20.25mg per actuation)
Basis of previous name rINN - Recommended International Non-proprietary
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.250
Unit dose form units gram
Unit dose unit of measure actuation
Virtual Product Ingredient
Ingredient Testosterone
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 16.200
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit gram
Ontology Drug Form & Route
Form & Route gel.transdermal
Dose Form
Formulation Transdermal gel
Drug Route
Route Transdermal
Controlled Drug Prescribing Information
Controlled Drug category Schedule 4 (CD Anab)
Actual Medicinal Products
Testogel 16.2mg/g gel (Besins Healthcare (UK) Ltd)
Virtual Medicinal Product Packs
Testosterone 16.2mg/g transdermal gel (20.25mg per actuation) 88 gram

dm+d data retrieved from TRUD: release NHSBSA_12.2.0_20241216000001, imported on 17th December 2024 at 04:01:15.

Feedback